Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

Rhea-AI Summary

Comera Life Sciences Holdings, Inc. (CMRA) announced its participation in the Benchmark Company’s 11th Annual Discovery One-on-One Investor Conference on December 1, 2022, at the New York Athletic Club. The company focuses on developing innovative biologic medicines aimed at enhancing patient access and self-administration. Comera's approach seeks to transform intravenous treatments into subcutaneous forms, allowing patients greater independence in their care. Interested parties can access the investor presentation on their official site for more details.

WOBURN, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced it will be participating in the Benchmark Company’s 11^th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York.

Interested parties can access a copy of Comera’s current investor presentation at: https://ir.comeralifesciences.com/

About Comera Life Sciences

Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms that can be self-administered. The goal of this approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen.

To learn more about the Comera Life Sciences mission, as well as the proprietary SQore™ platform, visit https://comeralifesciences.com/.

Contacts:

Comera Investor

John Woolford
ICR Westwicke
John.Woolford@westwicke.com  

Comera Press

Jon Yu
ICR Westwicke
ComeraPR@westwicke.com

FAQ

What is the CMRA conference on December 1, 2022?

Comera Life Sciences will participate in the Benchmark Company’s 11th Annual Discovery One-on-One Investor Conference.

Where is the Benchmark Company conference taking place?

The conference will be held at the New York Athletic Club, New York.

What is the focus of Comera Life Sciences?

They focus on developing biologic medicines that transition from intravenous to subcutaneous forms for self-administration.

How can I access Comera's investor presentation?

The current investor presentation can be accessed on Comera's official website.

What does the SQore™ platform do?

The SQore™ platform is used to transform biologic medicines to allow self-administration.